Mental Health

Health Tech By Mario Aguilar

Therapy chatbot startup Woebot raises $90 million

First Opinion By Susan T. Mahler

Physicians, mental illness, and the problem with ‘passing’

mental health infrastructure concept illo

First Opinion By Allen Frances

Ignoring mental health infrastructure will be a costly mistake

First Opinion Podcast By Patrick Skerrett

Listen: A biostatistician on the ‘gold mine’ in our sewers

First Opinion By Emil D. Kakkis

Aduhelm’s accelerated approval offers a promising roadmap for rare neurological diseases

Health By Kevin Lin

How a new buddy system is helping health workers grapple with Covid’s toll

First Opinion By Ken Marek

The approval of aducanumab isn’t the end of the story. It’s just the beginning

Health By Claudia López Lloreda

A safer, low dose of laughing gas may be enough to help some patients with major depression, study finds

First Opinion By Dana Goldman and Darius Lakdawalla

FDA’s approval of aducanumab paves the way for ‘more momentous’ Alzheimer’s breakthroughs

First Opinion By Brian Barnett, Rick Doblin, and Julie Holland

NIH: It’s time to make your mark on the renaissance of medicinal psychedelics

Health By Theresa Gaffney

New pediatricians are seeing few ‘bread and butter’ cases, but an influx of mental health crises

First Opinion By Jennifer Breen Feist and Corey Feist

Congress needs to pass the Dr. Lorna Breen act to support U.S. health care workers

Health Tech By Mario Aguilar

As Teladoc bolsters its mental health business, competitors make their case

Health By Lev Facher

Years ago, a syringe exchange helped end a devastating HIV outbreak. Now it might be forced to close

Health By Sara Reardon

Covid-19 gave scientists an opening to better understand how brain disorders arise

First Opinion By Diane O'Leary

Needed for long Covid: a less authoritarian approach to understanding, treatment

Health By Erin Brodwin

First-of-its-kind study pits psilocybin against a common antidepressant

First Opinion By Yotam Dagan

Beware the ‘last mile, first smile’ syndrome when we near the end of the Covid-19 pandemic

Health By Elizabeth Cooney

1 in 3 Covid-19 patients are diagnosed with a neuropsychiatric condition in the next six months, large study finds

First Opinion By Jennifer K. Brody, Ayana Jordan, and Sarah E. Wakeman

Excited delirium: valid clinical diagnosis or medicalized racism? Organized medicine needs to take a stand

Health By Theresa Gaffney

Kids in the ER are waiting longer for mental health care

First Opinion By Abigail Hardin

Fee or free? The services hospital-based psychologists provide are ‘priceless’

Health Tech By Mario Aguilar

Virtual therapy startups tackle the gap in mental health care for kids and teens

First Opinion Podcast By Patrick Skerrett

Jason Karlawish and an Alzheimer’s caregiver on dementia’s ripple effect

Health Tech By Mario Aguilar

Most Read

Long after the fire of a Covid-19 infection, mental and neurological effects can still smolder

As the Covid-19 crisis ebbs in the U.S., experts brace for some to experience psychological fallout

Listen: A sister on watching the mental health care system fail her brother

On a limb: Despite resistance, a group of researchers is investigating the possibility of a new mental health disorder

A resilience prescription for Covid-19 and other traumatic events

Ketamine gives hope to patients with severe depression. But some clinics stray from the science and hype its benefits

Anxious about a big speech? This startup wants to calm you down — with a cardiac drug you pop like a mint

Physicians aren’t ‘burning out.’ They’re suffering from moral injury

All Coverage

Therapy chatbot startup Woebot raises $90 million

Physicians, mental illness, and the problem with ‘passing’

Ignoring mental health infrastructure will be a costly mistake

Listen: A biostatistician on the ‘gold mine’ in our sewers

Aduhelm’s accelerated approval offers a promising roadmap for rare neurological diseases

How a new buddy system is helping health workers grapple with Covid’s toll

The approval of aducanumab isn’t the end of the story. It’s just the beginning

A safer, low dose of laughing gas may be enough to help some patients with major depression, study finds

FDA’s approval of aducanumab paves the way for ‘more momentous’ Alzheimer’s breakthroughs

NIH: It’s time to make your mark on the renaissance of medicinal psychedelics

New pediatricians are seeing few ‘bread and butter’ cases, but an influx of mental health crises

Congress needs to pass the Dr. Lorna Breen act to support U.S. health care workers

As Teladoc bolsters its mental health business, competitors make their case

Years ago, a syringe exchange helped end a devastating HIV outbreak. Now it might be forced to close

Covid-19 gave scientists an opening to better understand how brain disorders arise

Needed for long Covid: a less authoritarian approach to understanding, treatment

First-of-its-kind study pits psilocybin against a common antidepressant

Beware the ‘last mile, first smile’ syndrome when we near the end of the Covid-19 pandemic

1 in 3 Covid-19 patients are diagnosed with a neuropsychiatric condition in the next six months, large study finds

Excited delirium: valid clinical diagnosis or medicalized racism? Organized medicine needs to take a stand

Kids in the ER are waiting longer for mental health care

Fee or free? The services hospital-based psychologists provide are ‘priceless’

Virtual therapy startups tackle the gap in mental health care for kids and teens

Jason Karlawish and an Alzheimer’s caregiver on dementia’s ripple effect

Inside the battle over Talkspace and a grand experiment in mental health